Trial By Error

Tag: myalgic encephalomyelitis

  • More Nonsense from The Lancet Psychiatry

    David Tuller is academic coordinator of the concurrent masters degree program in public health and journalism at the University of California, Berkeley.   The PACE authors have long demonstrated great facility in evading questions they don’t want to answer. They did this in their response to correspondence about the original 2011 Lancet paper. They did it again…

  • Did the PACE Trial Really Prove that Graded Exercise Is Safe?

    By Julie Rehmeyer and David Tuller, DrPH Julie Rehmeyer is a journalist and Ted Scripps Environmental Journalism Fellow at the University of Colorado, Boulder, who has written extensively about ME/CFS. Joining me for this episode of our ongoing saga is my friend and colleague Julie Rehmeyer. In my initial series, I only briefly touched on the PACE trial’s blanket claim of…

  • Questions for Dr. White and his PACE Colleagues

    I have been seeking answers from the PACE researchers for more than a year. At the end of this post, I have included the list of questions I’d compiled by last September, when my investigation was nearing publication. Most of these questions remain unanswered. The PACE researchers are currently under intense criticism for having rejected…

  • A request for data from the PACE trial

    Mr. Paul Smallcombe Records & Information Compliance Manager Queen Mary University of London Mile End Road London E1 4NS Dear Mr Smallcombe: The PACE study of treatments for ME/CFS has been the source of much controversy since the first results were published in The Lancet in 2011. Patients have repeatedly raised objections to the study’s methodology and…

  • Why has the PACE Study’s “Sister Trial” Been “Disappeared” and Forgotten?

    In 2010, the BMJ published the results of the Fatigue Intervention by Nurses Evaluation, or FINE. The investigators for this companion trial to PACE, also funded by the Medical Research Council, reported no benefits to ME/CFS patients from the interventions tested. In medical research, null findings often get ignored in favor or more exciting “positive”…

  • Did the PACE Study Really Adopt a ‘Strict Criterion’ for Recovery?

    First, some comments: When Virology Blog posted my very, very, very long investigation of the PACE trial two weeks ago, I hoped that the information would gradually leak out beyond the ME/CFS world. So I’ve been overwhelmed by the response, to say the least, and technologically unprepared for my viral moment. I didn’t even have…

  • David Tuller responds to the PACE investigators

    David Tuller’s three-installment investigation of the PACE trial for chronic fatigue syndrome, “Trial By Error,” has received enormous attention. Although the PACE investigators declined David’s efforts to interview them, they have now requested the right to reply. Today, virology blog posts their response to David’s story, and below, his response to their response.  According to…

  • PACE trial investigators respond to David Tuller

    Professors Peter White, Trudie Chalder and Michael Sharpe (co-principal investigators of the PACE trial) respond to the three blog posts , published here on 21st, 22nd and 23rd October 2015, about the PACE trial. Overview The PACE trial was a randomized controlled trial of four non-pharmacological treatments for 641 patients with chronic fatigue syndrome (CFS) attending secondary care…

  • The Troubling Case of the PACE Chronic Fatigue Syndrome Study (final installment)

      A few years ago, Dr. Racaniello let me hijack this space for a long piece about the CDC’s persistent incompetence in its efforts to address the devastating illness the agency itself had misnamed “chronic fatigue syndrome.” Now I’m back with an even longer piece about the U.K’s controversial and highly influential PACE trial. The $8 million…

  • The Troubling Case of the PACE Chronic Fatigue Syndrome Study (second installment)

      A few years ago, Dr. Racaniello let me hijack this space for a long piece about the CDC’s persistent incompetence in its efforts to address the devastating illness the agency itself had misnamed “chronic fatigue syndrome.” Now I’m back with an even longer piece about the U.K’s controversial and highly influential PACE trial. The $8 million…

  • The Troubling Case of the PACE Chronic Fatigue Syndrome Study

      A few years ago, Dr. Racaniello let me hijack this space for a long piece about the CDC’s persistent incompetence in its efforts to address the devastating illness the agency itself had misnamed “chronic fatigue syndrome.” Now I’m back with an even longer piece about the U.K’s controversial and highly influential PACE trial. The…